Phage therapy program
TASK / Phages4TB consortium
| Status | Research/development |
|---|---|
| Type | Company |
| Location | Cape Town; South Africa |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Official EU project report says first-in-human TB trial package submitted March2025 following SAHPRA consultation June2024. Current approval, registry ID and recruitment not verified; TASK’s routine clinical-research contact is not an established phage therapy intake route. |
|---|---|
| Areas of work | Mycobacteriophage discovery, ex-vivo sputum work and clinical trial preparation for pulmonary tuberculosis; planned adjunctive antibiotics. |
| International access | Not stated in checked sources; do not infer eligibility from international collaborations. |
What to confirm
- The EU fellowship project ended April2025; this alone does not establish consortium inactivity or trial launch.
- Submission to SAHPRA is not an approval or a recruiting trial.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | za-task |
|---|